TEKT1

Tektin-1 · Q969V4 · TEKT1 on Sugi Atlas →

0 patent compounds predicted against TEKT1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TEKT1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Prevention of Renal Complications of Diabetes With Thiamine PHASE4UNKNOWN
Study of Sitravatinib With or Without Other Anticancer Therapies Receiving Clinical Benefit From Parent Study PHASE2/PHASE3COMPLETED
Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer PHASE3COMPLETED
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
Use of Regorafenib in Recurrent Epithelial Ovarian Cancer PHASE2COMPLETED
Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases PHASE2COMPLETED
68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease PHASE2UNKNOWN
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients PHASE2ENROLLING_BY_INVITATION
Anlotinib Plus Toripalimab as First-line Treatment for Advanced Gastric Cancer With ECOG 2 (APICAL-GC) PHASE2RECRUITING
Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor PHASE1UNKNOWN
Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC PHASE1COMPLETED
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
Cryopreservation of Prepubertal Testicular Tissue for Preservation of Fertility in Young Boys With Cancer nanRECRUITING
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients nanRECRUITING
Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD) nanCOMPLETED
Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial nanUNKNOWN
Inflammatory Breast Cancer, Tumor Markers, and Factors Associated With Angiogenesis nanCOMPLETED
Effect of Post Covid-19 Hypoxia on Placenta of Normal Pregnant Women: A Possible Role of Hypoxia Inducible Factor-1α. nanUNKNOWN
Hereditary Tubulointerstitial Nephritis nanCOMPLETED
ANgiogenic Function at NOrmal TErm on Placenta nanRECRUITING
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics nanCOMPLETED
Role of Polymorphisms in the Dectin-1 Gene in Determining the Risk of Candida Colonization and Infection in Critically Ill Patients nanUNKNOWN
Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects nanUNKNOWN
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients nanUNKNOWN
Cause of Familial Testicular Cancer nanCOMPLETED
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease nanRECRUITING
HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion nanACTIVE_NOT_RECRUITING
Hyperbaric Oxygen Therapy for Post Traumatic Stress Disorder nanCOMPLETED
sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TEKT1 binder may also engage these)

ProteinNameSimilarity
Q99JD2 1.000 Q99JD2 →
Q4R5V1 1.000 Q4R5V1 →
Q9DAJ2 1.000 Q9DAJ2 →
Q32KZ9 1.000 Q32KZ9 →
Q6AYM2 1.000 Q6AYM2 →
Q6AXV2 1.000 Q6AXV2 →
Q922G7 1.000 Q922G7 →
Q9TTW3 1.000 Q9TTW3 →
Q149S1 0.996 Q149S1 →
Q2T9Q6 0.996 Q2T9Q6 →
Q9UIF3 0.996 Q9UIF3 →
Q5PPV2 0.993 Q5PPV2 →
Q26648 0.993 Q26648 →
Q4R353 0.990 Q4R353 →
Q2TA38 0.989 Q2TA38 →
Q8WW24 0.988 Q8WW24 →
Q96M29 0.987 Q96M29 →
F7F3Q2 0.986 F7F3Q2 →
Q2YDI7 0.984 Q2YDI7 →
Q4V8G8 0.983 Q4V8G8 →
G5E8A8 0.982 G5E8A8 →
Q6X6Z7 0.980 Q6X6Z7 →
A6H782 0.969 A6H782 →
Q1W6C3 0.969 Q1W6C3 →
Q9BXF9 0.967 Q9BXF9 →
Q9D4K7 0.966 Q9D4K7 →
M1V4Y8 0.966 M1V4Y8 →
Q2YDN4 0.964 Q2YDN4 →
Q8IYK2 0.964 Q8IYK2 →
A8J8F6 0.963 A8J8F6 →